Expand EWTX Menu
EWTX MENU

EWTX Stock Summary and Trading Ideas (Edgewise Therapeutics | NASDAQ:EWTX)

Charts for Today's Stock Price and Implied Volatility in Edgewise Therapeutics

31-Dec-2025

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for EWTX by Theoretical Edge and Win Rates

Sentiment

News

Trading Statistics

Key Ratios

Edgewise Therapeutics (EWTX) Frequently Asked Questions

What does Edgewise Therapeutics do?

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

What symbol and exchange does Edgewise Therapeutics shares trade?

Edgewise Therapeutics trades on the NASDAQ stock market under the symbol EWTX.

What is Edgewise Therapeutics stock price doing today?

As of December 31, 2025, EWTX stock price climbed to $24.82 with 1,020,306 million shares trading.

What is Edgewise Therapeutics's Beta?

EWTX has a beta of 2.82, meaning it tends to be more sensitive to market movements. EWTX has a correlation of 0.27 to the broad based SPY ETF.

How much is Edgewise Therapeutics worth?

EWTX has a market cap of $2.63 billion. This is considered a Mid Cap stock.

What is the highest and lowest price Edgewise Therapeutics traded in the last 3 year period?

In the last 3 years, EWTX traded as high as $38.12 and as low as $5.12.

What are the top ETFs holding Edgewise Therapeutics?

The top ETF exchange traded funds that EWTX belongs to (by Net Assets): VTI, IWM, VXF, IWO, IBB.

Is Edgewise Therapeutics (EWTX) a good investment?

EWTX has underperformed the market in the last year with a return of -8.3%, while SPY returned +17.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in EWTX shares. However, EWTX has outperformed the market in the last 3 month and 2 week periods, returning +53.0% and +9.0%, while SPY returned +2.7% and +0.7%, respectively. This indicates EWTX has been having a stronger performance recently.

What are the support and resistance levels for Edgewise Therapeutics (EWTX)?

EWTX support price is $23.07 and resistance is $26.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EWTX shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes